To our Valued Research Participants,
Given the heightened community response surrounding coronavirus (COVID-19), Pharmasite Research is actively evaluating all research-related impacts surrounding this public health emergency. We are operating within the guidelines of the Centers for Disease Control (CDC), the Maryland Department of Health, and local health authorities, and will monitor their guidance as the situation continues. Any impact the situation may have on research participants will be communicated to you.
The health and safety of our participants and staff is our top priority. We are committed to maintaining ongoing research activity to the extent possible within available guidance from state and federal agencies. If you are currently taking part in a clinical trial with Pharmasite Research, or are interested participation, you may continue to do so provided the following precautions are observed:
If you are not feeling well, and have any of the following, please call our office before your appointment:
● Shortness of Breath
In addition, please notify our office if you have recently travelled abroad or have been exposed to anyone confirmed to have COVID-19.
Our staff will discuss alternatives to an in-person appointment if possible, or reschedule the appointment as needed. Please contact our team first at (410) 602-1440 if you have any questions.
For up to date information about COVID-19, please visit Maryland Department of Health, at https://coronavirus.maryland.gov/ and the Centers for Disease Control, at https://www.cdc.gov/.
We extend our best wishes for your continued health and well-being.
Director of Operations